MEDREG – Business News Updates

Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval

Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug

Eisai, Biogen say Alzheimer’s drug succeeds in slowing cognitive decline

U.S. authorizes second COVID booster for Americans 50 and older

COVID-19 pill developers aim to top Merck, Pfizer efforts